Arrowhead Pharmaceuticals Overview
Arrowhead Pharmaceuticals Target Price
Analysts' 12-month price predictions for ARWR.
Get informed when a big investor buys or sells
+ FollowShare Price
$71.91
Average Target Price
$78.67
9.4% upside
9.4% upside3 analysts in the last 4 months
High: $100 | Low: $46
Analyst Recommendations
No recommendations in the last 4 months.
Revenue & Income Forecast
Analysts' Target Prices
| Date | Analyst | Price Target | Current Upside/Downside | |
|---|---|---|---|---|
| 2026-05-13 | Bernstein | $46 |  36% downside |  |
| 2026-05-08 | Chardan Capital | $90 | 25.2% upside | |
| 2026-04-21 | Morgan Stanley | $100 | 39.1% upside | |
| 2026-02-06 | Morgan Stanley | $78 | 8.5% upside | |
| 2026-01-27 | Robert W. Baird | $81 | 12.6% upside | |
| 2026-01-21 | H.C. Wainwright | $100 | 39.1% upside | |
| 2026-01-13 | UBS | $110 | 53% upside | |
| 2026-01-13 | Piper Sandler | $110 | 53% upside | |
| 2026-01-07 | Morgan Stanley | $81 | 12.6% upside | |
| 2026-01-07 | Chardan Capital | $80 | 11.3% upside | |
| 2026-01-02 | Tudor PickeringWilliam Pickering | $35 | 51.3% downside | |
| 2025-12-31 | Bernstein | $35 | 51.3% downside | |
| 2025-12-17 | Piper SandlerEdward Tenthoff | $100 | 39.1% upside | |
| 2025-12-11 | RBC Capital | $80 | 11.3% upside | |
| 2025-12-02 | H.C. Wainwright | $85 | 18.2% upside | |
| 2025-11-26 | Morgan Stanley | $48 | 33.2% downside | |
| 2024-11-29 | BernsteinWilliam Pickering | $24 | 66.6% downside | |
| 2024-11-27 | Loop Capital MarketsKeay Nakae | $29.97 | 58.3% downside | |
| 2024-09-03 | CitigroupDavid Lebowitz | $27 | 62.5% downside | |
| 2024-07-05 | H.C. WainwrightPatrick Trucchio | $29.97 | 58.3% downside | |
| 2024-06-05 | Goldman SachsAndrea Tan | $31 | 56.9% downside | |
| 2024-05-30 | RBC CapitalLuca Issi | $24.98 | 65.3% downside | |
| 2023-02-07 | RBC Capital | $38.46 | 46.5% downside | |
| 2023-02-07 | Piper Sandler | $52 | 27.7% downside | |
| 2022-12-06 | H.C. Wainwright | $44.96 | 37.5% downside | |
| 2022-11-29 | Jefferies | $37.47 | 47.9% downside | |
| 2022-11-29 | Morgan Stanley | $37 | 48.5% downside | |
| 2022-11-29 | Leerink Partners | $31 | 56.9% downside | |
| 2022-01-19 | Goldman SachsMadhu Kumar | $85 | 18.2% upside | |